America’s Future Runs on Longevity Biotech, Not AI | Omri Amirav-Drory, NFX

Longevity biotech is America’s next trillion-dollar bet. In this exclusive interview, NFX General Partner Omri Amirav-Drory explains why solving aging, not AI, is the real deeptech revolution.From radically extending human lifespan to reversing fertility decline, Omri lays out the ABCD plan for aging, why 160 years is the next milestone, and how TechBio - computation meets biology - will transform healthcare, biotech, and the economy.Despite biotech’s brutal crash, he argues now is the best time to invest and reveals the breakthroughs in AI and synthetic biology that could unlock new anti-aging technologies and human superpowers.Hosted by Mgoes: https://x.com/m_goes_distance---00:00:00 – Intro00:03:30 – Longevity as America’s Next Deeptech Frontier00:07:07 – Aging Population & The Fertility Crisis00:10:34 – The ABCD Plan For Lifespan Extension00:14:28 – How Far Away Are We From Living To 160?00:25:19 – TechBio: Computation, AI, Biology Combined00:33:30 – Will AI Solve All Problems in Biology?00:39:10 – America First, Evolution, and Vaccine Skepticism00:56:05 – Biotech Boom And Bust, Is It A Good Time To Invest?01:07:13 – Will Synbio Give Us Superpowers?---The Accelerate Bio Podcast explores the future of human potential in the age of Artificial Intelligence.Subscribe for weekly deep-dive interviews, to stay ahead of the curve and navigate this new era.We feature news, breakthroughs, and conversations with founders, investors, and visionaries shaping science, biotechnology, human enhancement, big data, AI, health tech, longevity, and more.---Brought to you by BiohackerDAO - A community dedicated to exploring and funding frontier technologies in human enhancement.